Genetic correlates in trichotillomania - A case-control association study in the South African Caucasian population

Israel Journal of Psychiatry and Related Sciences

Volumn 43, Issue 2, 2006, Pages 93-101

  Hemmings, Sîan M J ^a   Kinnear, Craig J ^a   Lochner, Christine ^a   Seedat, Soraya ^a   Corfield, Valerie A ^a   Moolman Smook, Johanna C ^a   Stein, Dan J ^a,b  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33746191810     PISSN: 03337308     EISSN: 26172402     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Christenson GA, Chernoff-Clementz E, Clementz BA. Comparison of clinical characteristics in trichotillomania and obsessive-compulsive disorder. J Clin Psychiatry 1992;53:407-413.
2. th edition. Washington, DC: American Psychiatric, 1994.
3. Jenike MA. Obsessive-compulsive and related disorders: A hidden epidemic. N Engl J Med 1989;321:539-541.
4. Swedo SE, Leonard HL. Trichotillomania. An obsessive compulsive spectrum disorder? Psychiatr Clin North Am 1992;15:777-790.
5. Lenane MC, Swedo SE, Rapoport JL, Leonard H, Sceery W, Guroff JJ. Rates of Obsessive Compulsive Disorder in first degree relatives of patients with trichotillomania: A research note. J Child Psychol Psychiatry 1992;33:925-933.
6. King RA, Scahill L, Vitulano LA, Schwab-Stone M, Tercyak KP, Jr., Riddle MA. Childhood trichotillomania: Clinical phenomenology, comorbidity, and family genetics. J Am Acad Child Adolesc Psychiatry 1995;34:1451-1459.
7. Pauls DL, Raymond CL, Stevenson JM, Leckman JF. A family study of Gilles de la Tourette syndrome. Am J Hum Genet 1991;48:154-163.
8. Bienvenu OJ, Samuels JF, Riddle MA, Hoehn-Saric R, Liang KY, Cullen BA, Grados MA, Nestadet G. The relationship of obsessive-compulsive disorder to possible spectrum disorders: Results from a family study. Biol Psychiatry 2000;48:287-293.
9. Swedo SE, Leonard HL, Rapoport JL, Lenane MC, Goldberger EL, Cheslow DL. A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling). N Engl J Med 1989;321:497-501.
10. Stein DJ. Neurobiology of the obsessive-compulsive spectrum disorders. Biol Psychiatry 2000;47:296-304.
11. Van Ameringen M, Mancini C, Oakman JM, Farvolden P. The potential role of haloperidol in the treatment of trichotillomania. J Affect Disord 1999;56:219-226
12. O'Sullivan RL, Christenson GA, Stein DJ. Pharmacotherapy of trichotillomania. In: Stein DJ, Christenson GA, Hollander E, editors. Trichotillomania. Washington, DC: American Psychiatric, 1999.
13. van Minnen A, Hoogduin KA, Keijsers GP, Hellenbrand I, Hendriks GJ. Treatment of trichotillomania with behavioral therapy or fluoxetine: A randomized, waiting-list controlled study. Arch Gen Psychiatry 2003;60:517-522.
14. Baca-Garcia E, Salgado BR, Segal HD, Lorenzo CV, Acosta MN, Romero MA, Hernandez MD, Saiz-Ruiz J, Fernandez Piqueras J, de Leon J. A pilot genetic study of the continuum between compulsivity and impulsivity in females: The serotonin transporter promoter polymorphism. Prog Neuropsychopharmacol Biol Psychiatry 2005;29:713-717.
15. Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D, Lesch KP. Allelic variation of human serotonin transporter gene expression. J Neurochem 1996;66: 2621-2624.
16. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996;274:1527-1531.
17. Warren JT, Jr., Peacock ML, Rodriguez LC, Fink JK. An MspI polymorphism in the hyman serotonin receptor gene (HTR2): Detection by DGGE and RFLP analysis. Hum Mol Genet 1993;2:338.
18. Polesskaya OO, Sokolov BP. Differential expression of the "C" and "T" alleles of the 5-HT2A receptor gene in the temporal cortex of normal individuals and schizophrenics. J Neurosci Res 2002;67:812-822.
19. Khait VD, Huang YY, Zalsman G, Oquendo MA, Brent DA, Harkavy-Friedman JM, Mann JJ. Association of serotonin 5-HT2A receptor binding and the T102C polymorphism in depressed and healthy Caucasian subjects. Neuropsychopharmacology 2005;30:166-172.
20. Bray NJ, Buckland PR, Hall H, Owen MJ, O'Donovan MC. The serotonin-2A receptor gene locus does not contain common polymorphism affecting mRNA levels in adult brain. Mol Psychiatry 2004;9:109-114.
21. Tarazi FI, Baldessarini RJ. Dopamine D4 receptors: Significance for molecular psychiatry at the millennium. Mol Psychiatry 1999;4:529-538.
22. Rubinstein M, Phillips TJ, Bunzow JR, Falzone TL, Dziewczapolski G, Zhang G, Fang Y, Larson JL, McDougall JA, Chester JA, Saez C, Pugsley TA, Gershanik O, Low MJ, Grandy DK. Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine. Cell 1997;90:991-1001.
23. Okuyama Y, Ishiguro H, Toru M, Arinami T. A genetic polymorphism in the promoter region of DRD4 associated with expression and schizophrenia. Biochem Biophys Res Commun 1999;258:292-295.
24. Molloy AG, Waddington JL. Assessment of grooming and other behavioural responses to the D-1 dopamine receptor agonist SK & F 38393 and its R- and S-enantiomers in the intact adult rat. Psychopharmacology (Berl) 1987;92:164-168.
25. Wachtel SR, Brooderson RJ, White FJ. Parametric and pharmacological analyses of the enhanced grooming response elicited by the D1 dopamine receptor agonist SKF 38393 in the rat. Psychopharmacology (Berl) 1992;109:41-48.
26. Lucki I, Kucharik RF. Selective enhancement of grooming behaviour by the D1-agonist SKF 38293 in rats following the destruction of serotonin neurons. Annals of the New York Academy of Sciences 1988;525:420-422.
27. du Toit PL, van Kradenburg J, Niehaus D, Stein DJ. Comparison of obsessive-compulsive disorder patients with and without comorbid putative obsessive-compulsive spectrum disorders using a structured clinical interview. Compr Psychiatry 2001;42:291-300.
28. First MB, Spitzer RL, Gobbon M, Williams JBW. Structured clinical interview for DSM-IV Axis I disorders - Patient edition (SCID-I/P, Version 2.0, 8/98 revision). New York: New York State Psychiatric Institute, Biometrics Research Department, 1998.
29. Keuthen NJ, O'Sullivan RL, Ricciardi JN, Shera D, Savage CR, Borgmann AS, Jenike MA, Baer L. The Massachusetts General Hospital (MGH) Hairpulling Scale: 1. development and factor analyses. Psychother Psychosom 1995;64:141-145.
30. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR, Charney DS. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry 1989; 46:1006-1011.
31. Kinnear CJ, Niehaus DJ, Moolman-Smook JC, du Toit PL, van Kradenberg J, Weyers JB, Potgieter A, Mavais V, Emsley RA, Knowles JA, Corfield VA, Brink PA, Stein DJ. Obsessive-compulsive disorder and the promoter region polymorphism (5-HTTLPR) in the serotonin transporter gene (SLC6A4): A negative association study in the Afrikaner population. Int J Neuropsychopharmacol 2000;3:327-331.
32. Cichon S, Nothen MM, Stober G, Schroers R, Albus M, Maier W, Rietschal M, Korner J, Weigelt B, Franzek E, Wildenauer D, Fimmers R, Propping P. Systematic screening for mutations in the 5′-regulatory region of the human dopamine D1 receptor (DRD1) gene in patients with schizophrenia and bipolar affective disorder. Am J Med Genet 1996;67:424-428.
33. Masellis M, Basile V, Meltzer HY, Lieberman JA, Sevy S, Macciardi FM, Cola P, Howard A, Badri F, Nothen MM, Kalow W, Kennedy JL. Serotonin subtype 2 receptor genes and clinical response to clozapine in schizophrenia patients. Neuropsychopharmacology 1998;19: 123-132.
34. Parsons MJ, D'Souza UM, Arranz MJ, Kerwin RW, Makoff AJ. The -1438 A/G polymorphism in the 5-hydroxytryptamine type 2A receptor gene affects promoter activity. Biol Psychiatry 2004;56:406-410.
35. Lochner C, Seedat S, du Toit PL, Nel DG, Niehaus DJ, Sandler R, Stein DJ. Obsessive-compulsive disorder and trichotillomania: A phenomenological comparison. BMC Psychiatry 2005;13:2.
36. Wolff MC, Leander JD. Selective serotonin reuptake inhibitors decrease impulsive behavior as measured by an adjusting delay procedure in the pigeon. Neuropsychopharmacology 2002;27:421-429.
37. Dalley JW, Theobald DE, Eagle DM, Passetti F, Robbins TW. Deficits in impulse control associated with tonically-elevated serotonergic function in rat prefrontal cortex. Neuropsychopharmacology 2002;26:716-728.
38. Lee JH, Kim HT, Hyun DS. Possible association between serotonin transporter promoter region polymorphism and impulsivity in Koreans. Psychiatry Res 2003;118:19-24.
39. Scalzitti JM, Cervera LS, Smith C, Hensler JG. Serotonin2A receptor modulation of D1 dopamine receptor-mediated grooming behavior. Pharmacol Biochem Behav 1999;63:279-284.
40. Greer JM, Capecchi MR. Hoxb8 is required for normal grooming behavior in mice. Neuron 2002;33:23-34.
41. Abelson JF, Kwan KY, O'Roak BJ, Baek DY, Stillman AA, Morgan TM, Mathews CA, Pauls DL, Rasin MR, Gunel M, Davis NR, Ercan-Sencicek AG, Guez DH, Spertus JA, Leckman JF, Dure LS, Kurlan R, Singer HS, Gilbert DL, Farhi A, Louvi A, Lifton RP, Sestan N, State MW. Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science 2005;310:317-320.
42. Arnold PD, Rosenberg DR, Mundo E, Tharmalingam S, Kennedy JL, Richter MA. Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive-compulsive disorder: A preliminary study. Psychopharmacology (Berl) 2004;174:530-538.
43. Hall D, Dhilla A, Charalambous A, Gogos JA, Karayiorgou M. Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive-compulsive disorder. Am J Hum Genet 2003;73:370-376.
44. Zai G, Bezchlibnyk YB, Richter MA, Arnold P, Burroughs E, Barr CL, Kennedy JL. Myelin oligodendrocyte glycoprotein (MOG) gene is associated with obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet 2004;129:64-68.
45. Zai G, Arnold P, Burroughs E, Barr CL, Richter MA, Kennedy JL. Evidence for the gamma-amino-butyric acid type B receptor 1 (GABBR1) gene as a susceptibility factor in obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet 2005;134:25-29.
46. Grados MA, Walkup J, Walford S. Genetics of obsessive-compulsive disorder: New findings and challenges. Brain Dev 2003;25:S55-S61.
47. Pernerger TV. What's wrong with Bonferroni adjustments? BMJ 1998;316:1236-1238.
48. Macciardi F. Multiple testing in association studies: To correct or not to correct? Am J Med Genet 2003;122B:31-32.
49. Moolman-Smook JC, De Lange WJ, Bruwer EC, Brink PA, Corfield VA. The origins of hypertrophic cardiomyopathy-causing mutations in two South African subpopulations: A unique profile of both independent and founder events. Am J Hum Genet 1999;65:1308-1320.
50. De Jager T, Corbett CH, Badenhorst JC, Brink PA, Corfield VA. Evidence of a long QT founder gene with varying phenotypic expression in South African families. J Med Genet 1996;33:567-573.